Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.
It is with great pleasure that I invite you to Great Debates & Updates in Thoracic Malignancies, scheduled for July 2016 in San Francisco, CA. This one-day, educational activity will focus on controversial areas in the management of patients with lung and other thoracic cancers, as nationally-recognized thought leaders take opposing sides on topics of interest to physicians and their patients.
Using didactic presentations in conjunction with lively and instructive debates, this exciting and comprehensive conference will give practicing clinicians a thorough analysis of all currently available and emerging data. Recognized thought leaders will discuss and debate a variety of controversial topics, including management strategies for common mutations in lung cancer and utilization of molecular biomarker profile of the tumors to guide therapeutic decisions.
Upon successful completion of this CME activity, you will have increased confidence in your ability to select evidence-based treatment options for newly diagnosed and recurrent lung cancers, with consideration of the best combinations and sequence of agents, optimal use of multimodality therapy and timing of therapy.
The unique and instructive format of Great Debates & Updates in Thoracic Malignancies will keep you up-to-date in the field and give you expert insight into the management of your patients.I hope to see you there!
Ramaswamy Govindan, MD
For registration inquiries:
Tel.: +1 (678) 242 0906
Fax: +1 (770) 751 7334